METRONIDAZOLE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metronidazole Hydrochloride, and what generic alternatives are available?
Metronidazole Hydrochloride is a drug marketed by Abraxis Pharm and is included in one NDA.
The generic ingredient in METRONIDAZOLE HYDROCHLORIDE is metronidazole hydrochloride. There are eighteen drug master file entries for this compound. Additional details are available on the metronidazole hydrochloride profile page.
Summary for METRONIDAZOLE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Clinical Trials: | 513 |
Patent Applications: | 2,201 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METRONIDAZOLE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for METRONIDAZOLE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ministry of Health, France | Phase 3 |
Hôpital Necker-Enfants Malades | Phase 3 |
Institut Pasteur | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for METRONIDAZOLE HYDROCHLORIDE
US Patents and Regulatory Information for METRONIDAZOLE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abraxis Pharm | METRONIDAZOLE HYDROCHLORIDE | metronidazole hydrochloride | INJECTABLE;INJECTION | 070295-001 | Oct 15, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |